ReviewClinical and translational allergy2017
How to manage anaphylaxis in primary care.
Review in Clinical and translational allergy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 57 citations in OpenAlex.
- Severe anaphylactic reaction to contrast agent: teams are well prepared but should simulate the situations regularly.The British journal of radiology · 2025Article
- 10 practical priorities to prevent and manage serious allergic reactions: GAClinical and translational allergy · 2024Review
- Anaphylaxis in a Swiss university emergency department: clinical characteristics and supposed triggers.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024Article
- Article
- Awareness of anaphylaxis among public in Al-Ahsa City of Saudi Arabia: A cross-sectional study.PloS one · 2024Article
- Research Advances in Mast Cell Biology and Their Translation Into Novel Therapies for Anaphylaxis.The journal of allergy and clinical immunology. In practice · 2023Review
- Investigation of the underuse of adrenaline (epinephrine) and prognosis among patients with anaphylaxis at emergency department admission.Frontiers in medicine · 2023Article
- Clinical review: The suggested management pathway for urticaria in primary care.Clinical and translational allergy · 2022Review
- Physicians' knowledge and practice concerning diagnosis and management of anaphylaxis: The situation in Egypt.African journal of emergency medicine : Revue africaine de la medecine d'urgence · 2021Article
- Recent update on the management of anaphylaxis.Clinical and experimental emergency medicine · 2021Article
- The applications of eHealth technologies in the management of asthma and allergic diseases.Clinical and translational allergy · 2021Review
- The 10-Point Plan 2021: Updated Concepts for Improved Procedural Safety During Facial Filler Treatments.Clinical, cosmetic and investigational dermatology · 2021Article
- Increasing anaphylaxis events in Western Australia identified using four linked administrative datasets.The World Allergy Organization journal · 2020Article
- Medical malpractice related to drug-induced anaphylaxis: An analysis of lawsuit judgments in South Korea.Medicine · 2019Article
- Epidemiology of anaphylaxis and biphasic reaction in Japanese children.Acute medicine & surgeryArticle
- A survey of anaphylaxis etiology and treatment.Medical gas researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaphylaxis is defined as a severe life-threatening generalized or systemic hypersensitivity reaction characterized by rapidly developing airway and/or circulation problems. It presents with very different combinations of symptoms and apparently mild signs and can progress to fatal anaphylactic shock unpredictably. The difficulty in recognizing anaphylaxis is due, in part, to the variability of diagnostic criteria, which in turn leads to a delay in administration of appropriate treatment, thus increasing the risk of death. The use of validated clinical criteria can facilitate the diagnosis of anaphylaxis. Intramuscular epinephrine (adrenaline) is the medication of choice for the emergency treatment of anaphylaxis. Administration of corticosteroids and H1-antihistamines should not delay the administration of epinephrine, and the management of a patient with anaphylaxis should not end with the acute episode. Long-term management of anaphylaxis should include avoidance of triggers, following confirmation by an allergology study. Etiologic factors suspected in the emergency department often differ from the real causes of anaphylaxis. Evaluation of patients with a history of anaphylaxis should also include an assessment of personal data, such as age and comorbidities, which may increase the risk of severe reactions. Special attention should also be paid to co-factors, as these may easily confound the cause of the anaphylaxis. Patients experiencing anaphylaxis should administer epinephrine as soon as possible. Education (including the use of Internet and social media), written personalized emergency action plans, and self-injectable epinephrine have proven useful for the treatment of further anaphylaxis episodes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.